Publications by authors named "Peng-Xing He"

Claim this Profile
I
Inhibition of lysine-specific demethylase 1 enhances the sensitivity of the chemotherapeutic drug doxorubicin in gastric cancer cell.
Xu-Yang Zhang, Pan Hao, Jun-Wei Wang, Wen Zhao, Hong-Min Liu, Peng-Xing He

Mol Biol Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATRA promotes PD-L1 expression to control gastric cancer immune surveillance.
Zhi-Lu Ma, Yan-Li Ding, Jing Jing, Lin-Na Du, Xu-Yang Zhang, Peng-Xing He

Eur J Pharmacol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of programmed death ligand 1 (PD-L1) is associated with metastasis and differentiation in gastric cancer.
Peng-Xing He, Zhi-Lu Ma, Huan Han, Xu-Yang Zhang, Sheng-Hui Niu, Yi-Chao Zheng

Life Sci· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G226, a new epipolythiodioxopiperazine derivative, triggers DNA damage and apoptosis in human cancer cells in vitro via ROS generation.
Peng-xing He, Jie Zhang, Yong-sheng Che, Qiao-jun He, Yi Chen

Acta Pharmacol Sin· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G226, a novel epipolythiodioxopiperazine derivative, induces autophagy and caspase-dependent apoptosis in human breast cancer cells in vitro.
Peng-xing He, Yong-sheng Che, Qiao-jun He, Yi Chen, Jian Ding

Acta Pharmacol Sin· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis